4//SEC Filing
Jabbour Jerome D 4
Accession 0001493152-20-000116
CIK 0001582554other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:05 PM ET
Size
18.6 KB
Accession
0001493152-20-000116
Insider Transaction Report
Form 4
Jabbour Jerome D
DirectorPresident and CEO
Transactions
- Other
Common Stock, par value $0.0001 per share
2019-06-21+3,000→ 789,511 total - Award
Stock option (right to buy)
2020-01-01+1,000,000→ 1,000,000 totalExercise: $2.27Exp: 2030-01-01→ Common Stock (1,000,000 underlying)
Footnotes (2)
- [F1]Stock dividend, payable to all holders of records of Series B Preferred Stock of 200 shares of Common Stock for each share of Series B Preferred Stock.
- [F2]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2021 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2021.
Documents
Issuer
Matinas BioPharma Holdings, Inc.
CIK 0001582554
Entity typeother
Related Parties
1- filerCIK 0001698838
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:05 PM ET
- Size
- 18.6 KB